Cargando…
Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate wheth...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229779/ https://www.ncbi.nlm.nih.gov/pubmed/24946777 http://dx.doi.org/10.1186/cc13932 |
_version_ | 1782344166873759744 |
---|---|
author | Lima, Alexandre van Genderen, Michel E van Bommel, Jasper Klijn, Eva Jansem, Tim Bakker, Jan |
author_facet | Lima, Alexandre van Genderen, Michel E van Bommel, Jasper Klijn, Eva Jansem, Tim Bakker, Jan |
author_sort | Lima, Alexandre |
collection | PubMed |
description | INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate whether nitroglycerin could correct the parameters of abnormal peripheral circulation in resuscitated circulatory shock patients. METHODS: This interventional study recruited patients who had circulatory shock and who persisted with abnormal peripheral perfusion despite normalization of global hemodynamic parameters. Nitroglycerin started at 2 mg/hour and doubled stepwise (4, 8, and 16 mg/hour) each 15 minutes until an improvement in peripheral perfusion was observed. Peripheral circulation parameters included capillary refill time (CRT), skin-temperature gradient (Tskin-diff), perfusion index (PI), and tissue oxygen saturation (StO(2)) during a reactive hyperemia test (RincStO(2)). Measurements were performed before, at the maximum dose, and after cessation of nitroglycerin infusion. Data were analyzed by using linear model for repeated measurements and are presented as mean (standard error). RESULTS: Of the 15 patients included, four patients (27%) responded with an initial nitroglycerin dose of 2 mg/hour. In all patients, nitroglycerin infusion resulted in significant changes in CRT, Tskin-diff, and PI toward normal at the maximum dose of nitroglycerin: from 9.4 (0.6) seconds to 4.8 (0.3) seconds (P <0.05), from 3.3°C (0.7°C) to 0.7°C (0.6°C) (P <0.05), and from [log] -0.5% (0.2%) to 0.7% (0.1%) (P <0.05), respectively. Similar changes in StO(2) and RincStO(2) were observed: from 75% (3.4%) to 84% (2.7%) (P <0.05) and 1.9%/second (0.08%/second) to 2.8%/second (0.05%/second) (P <0.05), respectively. The magnitude of changes in StO(2) was more pronounced for StO(2) of less than 75%: 11% versus 4%, respectively (P <0.05). CONCLUSIONS: Dose-dependent infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue oxygenation in patients following circulatory shock resuscitation. Individual requirements of nitroglycerin dose to improve peripheral circulation vary between patients. A simple and fast physical examination of peripheral circulation at the bedside can be used to titrate nitroglycerin infusion. |
format | Online Article Text |
id | pubmed-4229779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42297792014-11-14 Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock Lima, Alexandre van Genderen, Michel E van Bommel, Jasper Klijn, Eva Jansem, Tim Bakker, Jan Crit Care Research INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate whether nitroglycerin could correct the parameters of abnormal peripheral circulation in resuscitated circulatory shock patients. METHODS: This interventional study recruited patients who had circulatory shock and who persisted with abnormal peripheral perfusion despite normalization of global hemodynamic parameters. Nitroglycerin started at 2 mg/hour and doubled stepwise (4, 8, and 16 mg/hour) each 15 minutes until an improvement in peripheral perfusion was observed. Peripheral circulation parameters included capillary refill time (CRT), skin-temperature gradient (Tskin-diff), perfusion index (PI), and tissue oxygen saturation (StO(2)) during a reactive hyperemia test (RincStO(2)). Measurements were performed before, at the maximum dose, and after cessation of nitroglycerin infusion. Data were analyzed by using linear model for repeated measurements and are presented as mean (standard error). RESULTS: Of the 15 patients included, four patients (27%) responded with an initial nitroglycerin dose of 2 mg/hour. In all patients, nitroglycerin infusion resulted in significant changes in CRT, Tskin-diff, and PI toward normal at the maximum dose of nitroglycerin: from 9.4 (0.6) seconds to 4.8 (0.3) seconds (P <0.05), from 3.3°C (0.7°C) to 0.7°C (0.6°C) (P <0.05), and from [log] -0.5% (0.2%) to 0.7% (0.1%) (P <0.05), respectively. Similar changes in StO(2) and RincStO(2) were observed: from 75% (3.4%) to 84% (2.7%) (P <0.05) and 1.9%/second (0.08%/second) to 2.8%/second (0.05%/second) (P <0.05), respectively. The magnitude of changes in StO(2) was more pronounced for StO(2) of less than 75%: 11% versus 4%, respectively (P <0.05). CONCLUSIONS: Dose-dependent infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue oxygenation in patients following circulatory shock resuscitation. Individual requirements of nitroglycerin dose to improve peripheral circulation vary between patients. A simple and fast physical examination of peripheral circulation at the bedside can be used to titrate nitroglycerin infusion. BioMed Central 2014 2014-06-19 /pmc/articles/PMC4229779/ /pubmed/24946777 http://dx.doi.org/10.1186/cc13932 Text en Copyright © 2014 Lima et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lima, Alexandre van Genderen, Michel E van Bommel, Jasper Klijn, Eva Jansem, Tim Bakker, Jan Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title | Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title_full | Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title_fullStr | Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title_full_unstemmed | Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title_short | Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
title_sort | nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229779/ https://www.ncbi.nlm.nih.gov/pubmed/24946777 http://dx.doi.org/10.1186/cc13932 |
work_keys_str_mv | AT limaalexandre nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock AT vangenderenmichele nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock AT vanbommeljasper nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock AT klijneva nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock AT jansemtim nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock AT bakkerjan nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock |